Antimicrobial activity of new anti-Pseudomonas beta-lactam-beta-lactamase inhibitors against Pseudomonas aeruginosa respiratory isolates recovered during the study for Monitoring Antimicrobial Resistance Trends (SMART) program in France (2016–2022)
Authors:
- 13 March 2025
- journal article
- Published by Elsevier in Infectious Diseases Now
- Vol. 55 (4) , 105056
Abstract
No abstract availableKeywords
Funding Information
- Merck Sharp and Dohme France
This publication has 24 references indexed in Scilit:
- Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE GroupClinical Microbiology and Infection, 2023
- In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020International Journal of Antimicrobial Agents, 2023
- Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa – Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020International Journal of Infectious Diseases, 2022
- Prevalence of antibiotic resistance of Pseudomonas aeruginosa in cystic fibrosis infection: A systematic review and meta-analysisMicrobial Pathogenesis, 2022
- The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An UpdateDrugs, 2021
- Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018International Journal of Infectious Diseases, 2021
- Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016International Journal of Antimicrobial Agents, 2020
- Activity of ceftolozane–tazobactam and comparators against Pseudomonas aeruginosa from patients in different risk strata – SMART United States 2016–2017Journal of Global Antimicrobial Resistance, 2020
- Antibiotic resistance in Pseudomonas aeruginosa – Mechanisms, epidemiology and evolutionDrug Resistance Updates, 2019
- Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategiesBiotechnology Advances, 2019